Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

UK authorities not funding paclitaxel for ovarian cancer

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    UK authorities not funding paclitaxel for ovarian cancer. Pharmacoecon. Outcomes News 189, 11 (1998). https://doi.org/10.1007/BF03285728

    Download citation

    Keywords

    • Ovarian Cancer
    • Paclitaxel
    • Carboplatin
    • Taxol
    • Local Health Authority